^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    PRGN-3005

    i
    Other names: PRGN-3005 UltraCAR-T, PRGN-3005
    Associations
    News
    Trials
    Company:
    Precigen
    Drug class:
    IL-15-targeted CAR-T immunotherapy, MUC16-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News
    Trials